| abstract |
Disclosed is a drug capable of effectively increasing a patient's blood active GLP-1 level. A combination therapy comprising a DPP4 inhibitor and an SGLT inhibitor. Examples of SGLT inhibitors include The compound shown by these is used. This combination increases plasma GLP-1 levels and is useful for the prevention or treatment of conditions such as diabetes and diabetes related diseases. [Selection figure] None |